Stock data
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL) reported net income of -US$71.37M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$78.58M | -US$71.37M | — |
| 2024 | — | — | -US$73.54M | -US$74.14M | — |
| 2023 | — | — | -US$159.17M | -US$156.09M | — |
| 2022 | — | — | -US$226.46M | -US$223.18M | — |
| 2021 | US$0.00M | — | -US$155.56M | -US$156.79M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.30M | — |
| 2026-03-31 | — | -US$4.20M | — |
| 2025-12-31 | — | -US$8.19M | — |
| 2025-09-30 | — | -US$13.59M | — |
| 2025-06-30 | — | -US$21.39M | — |
| 2025-03-31 | — | -US$28.20M | — |
| 2024-12-31 | — | -US$11.89M | — |
| 2024-09-30 | — | -US$23.02M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.